Rockefeller Capital Management
SSKN

Rockefeller Capital Management’s Strata Skin Sciences SSKN Stock Holding History

Rockefeller Capital Management’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-45
Closed – – 3381
2020
Q4 		$0 Buy
+45
New +$648 ﹤0.01% 2998

Other funds holding SSKN

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rockefeller Capital Management's SSKN Position: Q1 2021 in Review

Rockefeller Capital Management sold out of Strata Skin Sciences (SSKN) in Q1 2021, closing a stake of 45 shares.

Rockefeller Capital Management first reported a position in SSKN in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 16 funds tracked by Wall St. Rank hold SSKN as of Q1 2021.

  • Rockefeller Capital Management reported no remaining Strata Skin Sciences position as of Q1 2021 after selling out during the quarter.
  • Rockefeller Capital Management sold 45 Strata Skin Sciences shares in Q1 2021.
  • Rockefeller Capital Management first reported a position in Strata Skin Sciences in Q4 2020 and held it in 1 quarter.
  • Rockefeller Capital Management's Strata Skin Sciences position peaked at $0 in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q1 2021.

Based on Rockefeller Capital Management's 13F filing for Q1 2021, filed 11 May 2021.